PubMed · 1995 · 112 citations · 0 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMolecular OncologyNeurogeneticsMalignant NeoplasmsMyc Family OncogenesOncogene AmplificationTumor Suppressor Gene InactivationTumor Suppressor GenesDeletion MappingMyc AmplificationMyc In NeuroblastomaNeuroblastoma BiologyTumor Suppressor Gene AnalysisTumor Suppressor Gene Deletions
Neuroblastoma is characterized by deletions of the short arm of chromosome 1 (1p) and amplification of the N-myc oncogene. We have made somatic cell hybrids of two human neuroblastoma cell lines, one with and one without N-myc expression and amplification. The expression of the amplified N-myc gene is completely switched off in the hybrids. This suggests that N-myc expression results from loss of a repressor function. As N-myc amplification is associated with loss of heterozygosity (LOH) of 1p36, we analysed 1p deletions in 16 neuroblastoma cell lines. The seven cell lines without N-myc amplification have no deletions or relatively small deletions, with an SRO on 1p36.23-33. This suggests that a tumor suppressor gene maps in this region. All nine cell lines with N-myc amplification have larger deletions, with an SRO from 1p35-36.1 to the telomere. This suggests that a second tumor suppressor gene which is associated with N-myc amplification maps more proximally. Fine mapping of 1p36 deletions in the two cell lines of the fusion experiment suggests that the distal locus is not a repressor of N-myc expression, but the more proximal locus could be a candidate for this function.